Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 1,251

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Bacterial Meningitis in the United States in 1995

Schuchat, Anne, Robinson, Katherine, Wenger, Jay D., Harrison, Lee H., Farley, Monica, Reingold, Arthur L., Lefkowitz, Lewis, Perkins, Bradley A.·1997·New England Journal of Medicine

Abstract

BACKGROUND: Before the introduction of the conjugate vaccines, Haemophilus influenzae type b was the major cause of bacterial meningitis in the United States, and meningitis was primarily a disease of infants and young children. We describe the epidemiologic features of bacterial meningitis five years after the H. influenzae type b conjugate vaccines were licensed for routine immunization of infants. METHODS: Data were collected from active, population-based surveillance for culture-confirmed meningitis and other invasive bacterial disease during 1995 in laboratories serving all the acute care hospitals in 22 counties of four states (total population, more than 10 million). The rates were compared with those for 1986 obtained by similar surveillance. RESULTS: On the basis of 248 cases of bacterial meningitis in the surveillance areas, the rates of meningitis (per 100,000) for the major pathogens in 1995 were Streptococcus pneumoniae, 1.1; Neisseria meningitidis, 0.6; group B streptococcus, 0.3; Listeria monocytogenes, 0.2; and H. influenzae, 0.2. Group B streptococcus was the predominant pathogen among newborns, N. meningitidis among children 2 to 18 years old, and S. pneumoniae among adults. Pneumococcal meningitis had the highest case fatality rate (21 percent) and in 36 percent of cases was caused by organisms that were not susceptible to penicillin. From these data, we estimate that 5755 cases of bacterial meningitis were caused by these five pathogens in the United States in 1995, as compared with 12,920 cases in 1986, a reduction of 55 percent. The median age of persons with bacterial meningitis increased greatly, from 15 months in 1986 to 25 years in 1995, largely as a result of a 94 percent reduction in the number of cases of H. influenzae meningitis. CONCLUSIONS: Because of the vaccine-related decline in meningitis due to H. influenzae type b, bacterial meningitis in the United States is now a disease predominantly of adults rather than of infants and young children.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejm199710023371404

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 37

  1. Ward J, Lieberman JM, Cochi SL. Haemophilus influenzae vaccines. In: Plotkin SA, Mortimer EA Jr, eds. Vaccines. 2nd ed. Philadelphia: W.B. Saunders, 1994:337-86.
  2. 10.1001/jama.253.4.521 · doi:10.1001/jama.253.4.521
  3. 10.1093/infdis/162.6.1316 · DOI · Paper page
  4. 10.1001/jama.269.2.221 · DOI
  5. 10.1288/00005537-199406000-00013 · DOI
  6. 10.1016/0140-6736(92)90529-C · DOI
  7. Scheifele DW, 1996, Can Med Assoc J, 154, 1041
  8. 10.1056/NEJM199703063361007 · DOI · Paper page
  9. 10.1093/infdis/127.3.271 · DOI
  10. Fraser DW, 1974, Am J Epidemiol, 100, 29, 10.1093/oxfordjournals.aje.a112005 · DOI
  11. Fraser DW, 1975, Am J Epidemiol, 102, 394, 10.1093/oxfordjournals.aje.a112178 · doi:10.1093/oxfordjournals.aje.a112178
  12. Schoendorf KC, 1994, Pediatrics, 93, 663
  13. 10.1016/0732-8893(86)90143-4 · doi:10.1016/0732-8893(86)90143-4
  14. Jorgensen JH, 1990, Antimicrob Agents Chemother, 34, 2075, 10.1128/AAC.34.11.2075 · DOI · Paper page
  15. 10.1001/jama.271.23.1831 · DOI
  16. 10.1084/jem.82.6.445 · DOI · Paper page
  17. Rodrigues LP, 1971, J Immunol, 107, 1071, 10.4049/jimmunol.107.4.1071 · doi:10.4049/jimmunol.107.4.1071
  18. 10.1084/jem.129.6.1349 · DOI · Paper page
  19. 10.1093/infdis/164.5.982 · DOI · Paper page
  20. 10.1016/S0022-3476(05)83529-2 · DOI · Paper page
  21. 10.1097/00006454-199307000-00009 · DOI
  22. 10.1001/jama.273.5.383 · doi:10.1001/jama.273.5.383 · Paper page
  23. 10.1001/jama.273.5.390 · doi:10.1001/jama.273.5.390 · Paper page
  24. 1997, MMWR Morb Mortal Wkly Rep, 46, 1
  25. Frasch CE, 1989, Clin Microbiol Rev, 2, S134, 10.1128/CMR.2.Suppl.S134 · doi:10.1128/cmr.2.suppl.s134
  26. 10.1016/0140-6736(91)91961-S · DOI · Paper page
  27. Sierra GVG, 1991, NIPH Ann, 14, 195
  28. 10.1016/0140-6736(92)93086-3 · DOI · Paper page
  29. 1996, MMWR Morb Mortal Wkly Rep, 45, 853
  30. 1996, MMWR Morb Mortal Wkly Rep, 45, 1
  31. 10.1542/peds.99.3.489 · DOI · Paper page
  32. 10.1172/JCI119042 · DOI · Paper page
  33. 10.1001/jama.267.15.2041 · doi:10.1001/jama.267.15.2041 · Paper page
  34. 10.1001/jama.273.14.1118 · doi:10.1001/jama.273.14.1118
  35. 1996, MMWR Morb Mortal Wkly Rep, 45, 1010
  36. 10.1093/infdis/173.2.365 · DOI
  37. 10.1056/NEJM199508243330803 · DOI · Paper page

Cited by

See all 1,251

Metadata

Authors
Schuchat, A., Robinson, K., Wenger, J. D., Harrison, L. H., Farley, M., Reingold, A. L., Lefkowitz, L., & Perkins, B. A.
Venue
New England Journal of Medicine
Published
1997-10-02
Volume
337
Issue
14
Pages
970-976
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2324125498
Cited by
1,251
References
1
FWCI
40.83
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Bacterial Meningitis in the United States in 1995. https://app.cochat.ai/papers/10.1056/nejm199710023371404
The paper
Schuchat, A., Robinson, K., Wenger, J. D., Harrison, L. H., Farley, M., Reingold, A. L., Lefkowitz, L., & Perkins, B. A. (1997). Bacterial Meningitis in the United States in 1995. New England Journal of Medicine. https://doi.org/10.1056/nejm199710023371404

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.